Dr. Russell Medford PhD

Russell Medford

Dr. Russell Medford PhD | Director

Dr. Medford was appointed to the board in February 2017. He is a managing partner of the Salutramed Group, LLC, a life sciences management consultancy, and has extensive private and public company expertise. He also serves as chief executive officer of healthEgames, Inc., a digital healthcare company and serves as the executive chairman of ViaMune, Inc., an immuno-oncology company. Dr. Medford has served as the co-founder, president, chief executive officer and director of AtheroGenics, Inc. and was a founding board member of Inhibitex, Inc., serving on its board until its acquisition by Bristol-Myers-Squibb in 2012. He has led companies through multiple stages of research and development, advancing novel, first-in-man clinical candidates for the treatment of cardiovascular disease, diabetes and arthritis. Dr. Medford obtained his M.D. and Ph.D. from the Albert Einstein College of Medicine.